Tsuchimoto Kim R

Monopar Therapeutics Inc. · Director

Tsuchimoto Kim R is listed in filings as Director at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 8, 2025, including sale activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Jul 2, 2024 to Dec 8, 2025. Reported amounts are shown as $222.0K to $45. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.